Natco Pharma Limited has informed the Exchange regarding a press release dated February 14, 2026, titled "NATCO receives approval from Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India".
Press Release Feb 14 2026
Filed with NSE · · 2 pages · English
Release
Earlier from NATCO Pharma
- Press Release Feb 13 2026
- Press Release Feb 03 2026
- Press Release Jan 30 2026
- Press Release Nov 21 2025
- Press Release Nov 12 2025
Later from NATCO Pharma
- Natco Pharma Limited Press Release Mar 03 2026
- Press Release Mar 20 2026
- India’s Natco Pharma to expand into Nigeria, demerge agrochemicals unit
- Press Release Jun 03 2026
- Natco Pharma Limited Press Release Jul 14 2026
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma